Theratechnologies Inc.
Biopharma company commercializing therapies for multi-drug resistant HIV and lipodystrophy.
THTX | US
Overview
Corporate Details
- ISIN(s):
- CA88338H1001 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 2015 PEEL STREET, 0 MONTREAL
- Website:
- https://www.theratech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Theratechnologies Inc. is a specialty biopharmaceutical company focused on developing and commercializing innovative therapies that address unmet medical needs, particularly within the field of Human Immunodeficiency Virus (HIV). The company's commercial portfolio includes two key products approved in the United States: Trogarzo®, a monoclonal antibody for treating multi-drug resistant HIV-1, and EGRIFTA SV®/EGRIFTA WR™ (tesamorelin), a therapy for reducing excess abdominal fat in adults with HIV and lipodystrophy. In September 2025, the company announced the completion of its acquisition by Future Pak.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Theratechnologies Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theratechnologies Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theratechnologies Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
